Literature DB >> 12439277

Extraarticular pigmented villonodular synovitis: a cause for failed knee arthroscopy.

Kingsley R Chin1, Gregory W Brick.   

Abstract

Arthroscopic treatment of diffuse pigmented villonodular synovitis of the knee is reported to have low recurrence rates and morbidity. The purpose of the current study was to evaluate demographic information, clinical symptoms, treatment parameters, and functional outcome in a group of 38 consecutive patients referred to the authors' hospital with persistent extraarticular diffuse pigmented villonodular synovitis of the knee after arthroscopic synovectomy. There were 23 males and 15 females with an average age of 31.7 years (range, 11-65 years) at the time of arthroscopy. All had an average of 1.7 (range, 1-5) arthroscopies. Thirty-four of 38 (89.5%) patients had some improvements of their symptoms after arthroscopic synovectomy, but all had worse symptoms and function at the latest followup of 3.63 years (range, 0.25-19.5 years). Although arthroscopic synovectomy offered some short-term relief, a critical review of prior reports and the data in the current study suggest poor outcomes in patients who have extraarticular diffuse pigmented villonodular synovitis of the knee after arthroscopic synovectomy. Magnetic resonance imaging is recommended for accurate staging of the disease and for long-term followup after arthroscopic treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12439277

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  15 in total

Review 1.  Evaluation and treatment of disorders of the infrapatellar fat pad.

Authors:  Jason L Dragoo; Christina Johnson; Jenny McConnell
Journal:  Sports Med       Date:  2012-01-01       Impact factor: 11.136

2.  Pigmented Villonodular Synovitis of the Knee Joint: A Case Report.

Authors:  Chirag Kapoor; Maulik Jhaveri; Rishit Soni; Malkesh Shah; Parth Rathi; Paresh Golwala
Journal:  Cureus       Date:  2016-10-04

3.  Does combined open and arthroscopic synovectomy for diffuse PVNS of the knee improve recurrence rates?

Authors:  Matthew W Colman; Jason Ye; Kurt R Weiss; Mark A Goodman; Richard L McGough
Journal:  Clin Orthop Relat Res       Date:  2013-03       Impact factor: 4.176

4.  Results and recurrence of pigmented villonodular synovitis of the ankle: does diffuse PVNS with extra-articular extension tend to recur more often?

Authors:  QinWei Guo; WeiLi Shi; Chen Jiao; Xing Xie; Dong Jiang; YueLin Hu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-04-07       Impact factor: 4.342

5.  Simultaneous anterior and posterior synovectomies for treating diffuse pigmented villonodular synovitis.

Authors:  Wei-Ming Chen; Po-Kuei Wu; Chien-Lin Liu
Journal:  Clin Orthop Relat Res       Date:  2012-02-23       Impact factor: 4.176

6.  Arthroscopic synovectomy in pigmented villonodular synovitis of the knee: clinical series and outcome.

Authors:  Jitesh K Jain; J V S Vidyasagar; Radha Sagar; Hiren Patel; Matad Lokeshwaraiah Chetan; Ashish Bajaj
Journal:  Int Orthop       Date:  2013-07-17       Impact factor: 3.075

7.  One step open synovectomy without adjuvant therapy for diffuse pigmented villonodular synovitis of the knee in a soccer player.

Authors:  Francesco Oliva; Antonio Frizziero
Journal:  Muscles Ligaments Tendons J       Date:  2011-10-30

8.  Outcomes after excision of pigmented villonodular synovitis of the knee.

Authors:  Vivek Sharma; Edward Y Cheng
Journal:  Clin Orthop Relat Res       Date:  2009-06-20       Impact factor: 4.176

9.  Tenosynovial giant cell tumour (pigmented villonodular synovitis-)-like changes in periprosthetic interface membranes.

Authors:  Stephan Söder; Stefan Sesselmann; Thomas Aigner; Stephan Oehler; Abbas Agaimy
Journal:  Virchows Arch       Date:  2015-11-09       Impact factor: 4.064

10.  Long-term functional outcomes of diffuse pigmented villonodular synovitis of knee: The role of adjuvant radiotherapy.

Authors:  Ju Chun Chien; Yi Ping Wei; Chun Yu Chen; Wei Hsin Hsiang; Yuan You Wang; Wen Shan Liu; Shan Wei Yang
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.